Ad is loading...
NPFCX
Price
$61.07
Change
+$0.25 (+0.41%)
Updated
Nov 22 closing price
PRGSX
Price
$67.50
Change
+$0.46 (+0.69%)
Updated
Nov 22 closing price
Ad is loading...

NPFCX vs PRGSX

Header iconNPFCX vs PRGSX Comparison
Open Charts NPFCX vs PRGSXBanner chart's image
American Funds New Perspective C
Price$61.07
Change+$0.25 (+0.41%)
VolumeN/A
CapitalizationN/A
T. Rowe Price Global Stock
Price$67.50
Change+$0.46 (+0.69%)
VolumeN/A
CapitalizationN/A
NPFCX vs PRGSX Comparison Chart
Loading...
View a ticker or compare two or three
VS
NPFCX vs. PRGSX commentary
Nov 23, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NPFCX is a StrongBuy and PRGSX is a StrongBuy.

FUNDAMENTALS
Fundamentals
NPFCX has more cash in the bank: 144B vs. PRGSX (6.86B). PRGSX pays higher dividends than NPFCX: PRGSX (0.24) vs NPFCX (0.20). NPFCX was incepted earlier than PRGSX: NPFCX (24 years) vs PRGSX (29 years). PRGSX is a more actively managed with annual turnover of: 102.50 vs. NPFCX (17.00). NPFCX has a lower initial minimum investment than PRGSX: NPFCX (250) vs PRGSX (2500). PRGSX annual gain was more profitable for investors over the last year : 21.93 vs. NPFCX (16.81). PRGSX return over 5 years is better than : 53.47 vs. NPFCX (36.67).
NPFCXPRGSXNPFCX / PRGSX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence24 years29 years-
Gain YTD16.11317.01995%
Front LoadN/AN/A-
Min. Initial Investment250250010%
Min. Initial Investment IRAN/AN/A-
Net Assets144B6.86B2,098%
Annual Yield % from dividends0.200.2483%
Returns for 1 year16.8121.9377%
Returns for 3 years-9.89-9.36106%
Returns for 5 years36.6753.4769%
Returns for 10 years60.23157.7938%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TRGP207.694.85
+2.39%
Targa Resources Corp
PZG0.380.01
+1.34%
Paramount Gold Nevada Corp
PEBO35.230.44
+1.26%
Peoples Bancorp
GMS99.100.80
+0.81%
GMS
FATE2.07-0.15
-6.76%
Fate Therapeutics